methylergonovine has been researched along with dihydroergotamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aupy, M; Henry, PY; Lafforgue, JL; Larre, P; Orgogozo, JM | 1 |
| INGELMAN-SUNDBERG, A; LINDGREN, L; RYDEN, G; SANDBERG, F | 1 |
| DAVID, NA; KIRCHHOF, AC | 1 |
| Evans, RW; Saper, JR | 1 |
2 review(s) available for methylergonovine and dihydroergotamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral methylergonovine maleate for refractory migraine and cluster headache prevention.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Female; Humans; Methylergonovine; Migraine Disorders | 2013 |
4 other study(ies) available for methylergonovine and dihydroergotamine
| Article | Year |
|---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Reversible cerebral arteriopathy associated with the administration of ergot derivatives.
Topics: Adult; Anti-Bacterial Agents; Cerebral Arterial Diseases; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Interactions; Ergotamine; Ergotamines; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Methylergonovine; Norgestrel | 1984 |
In vitro studies of the motility of the human uterus. IV. The effects of oxytocin, methylergometrine, dihydroergotamine and two new oxytocics on the spontaneous motility in different parts of the pregnant and nonpregnant uterus.
Topics: Cell Movement; Dihydroergotamine; Female; Humans; In Vitro Techniques; Methylergonovine; Oxytocics; Oxytocin; Pregnancy; Research; Uterus | 1959 |
Further studies on two new lysergic acid compounds; d-lysergic acid-dl-hydroxybutylamide-2 (methergine) and dihydroergotamine (D.H.E. 45).
Topics: Dihydroergotamine; Lysergic Acid; Methylergonovine | 1947 |